Lingqun Ye

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Hongmei Luo, Dan Zhang, Fangfang Wang, Qiang Wang, Yu Wu, Maling Gou, Yiguo Hu, Wenyan Zhang, Jingcao Huang, Yuping Gong, Ling Pan, Tianshu Li, Pan Zhao, Danfeng Zhang, Ying Qu, Zhigang Liu, Tao Jiang, Yang Dai, Tingting Guo, Jiang Zhu, Lingqun Ye, Li Zhang, Weiping Liu, Qing Yi, Yuhuan Zheng
ALCAM-EGFR interaction regulates myelomagenesis. Blood advances 5 (23) (2022)
Qiang Wang, Zhijuan Lin, Zhuo Wang, Lingqun Ye, Miao Xian, Liuling Xiao, Pan Su, Enguang Bi, Yung-Hsing Huang, Jianfei Qian, Lintao Liu, Xingzhe Ma, Maojie Yang, Wei Xiong, Youli Zu, Sai Ravi Pingali, Bing Xu, Qing Yi
RARγ activation sensitizes human myeloma cells to carfilzomib treatment through OAS-RNase L innate immune pathway. Blood (2021)

Lingqun Ye.css-eqlu8i{font-size:small;padding-left:4px;}